MPG
ATYR

My Portfolio Guide’s aTyr Pharma ATYR Stock Holding History

My Portfolio Guide’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.46K Buy
+7,000
New +$5.91K ﹤0.01% 133

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

My Portfolio Guide's ATYR Position: Q1 2026 in Review

My Portfolio Guide opened a new position in aTyr Pharma (ATYR) in Q1 2026: 7,000 shares worth $5.46K. The stake represents ﹤0.01% of the portfolio and ranks #133 among its holdings.

111 funds tracked by Wall St. Rank hold ATYR as of Q1 2026.

  • My Portfolio Guide held 7,000 shares of aTyr Pharma worth $5.46K as of Q1 2026.
  • aTyr Pharma was a new My Portfolio Guide position in Q1 2026.
  • aTyr Pharma made up ﹤0.01% of My Portfolio Guide's portfolio in Q1 2026, its #133 holding.
  • 111 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2026.

Based on My Portfolio Guide's 13F filing for Q1 2026, filed 6 May 2026.